Delos Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Cloverbiopharmacloverbiopharma.comin𝕏Mar 2026
Clover Biopharma is a commercial-stage biotechnology company that develops vaccines using its Trimer-Tag technology platform along with in-house manufacturing and commercial capabilities.
BiotechHealthtechChengdu
Peng Liang(Executive Officer, Director, Promoter)Joshua Liang(Executive Officer, Director)
BoardXiaodong Wang(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.